Ancrod: clinical indications and methods of use.
Wright
J G
JG
Department of Surgery, Ohio State University College of Medicine, Columbus, USA.
Geroulakos
G
G
D000721:Ancrod / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D001809:Blood Viscosity / Q000187:drug effects; D005342:Fibrinolysis / Q000187:drug effects; D005921:Glomerulonephritis / Q000188:drug therapy; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D007511:Ischemia / Q000188:drug therapy; D007866:Leg / Q000098:blood supply; D011655:Pulmonary Embolism / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D012039:Regional Blood Flow / Q000187:drug effects; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000188:drug therapy; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D000925:Anticoagulants; D013300:Streptokinase; D000721:Ancrod; D014568:Urokinase-Type Plasminogen Activator